Microplate technology allows both miniaturization and high-throughput to merge in an effort to streamline the drug discovery process, which is critical to the pharmaceutical industry. Microplate readers allow researchers to perform a variety of different assays efficiently and precisely as a result of their high-throughput adaptability and robotics. Furthermore, these assays provide the advantages of reducing labor time, raw material costs and sample volume. Although the microplate reader market is well established, it is expanding due to the dynamic nature of the platform. The investigation of end-user needs in High-Throughput Screening (HTS) can be leveraged across several product categories with the goals of developing better products and expanding market penetration. To this end, the survey data has been placed in context by cross-tabulating it with the responses to an initial 14-question survey designed to provide baseline data on the nature of the respondent's drug discovery research. Included in these cross-tabulations are: the stage of research, type of research, disease targets, biological processes studied, and other related products and services used regularly. The results of the seven surveys conducted for this unique series of reports clearly shows that past distinctions between the stages of drug discovery are diminishing. High-Throughput Screening (HTS) is structured to reflect the market's integration, while highlighting end-user problems that represent exciting market opportunities for life science suppliers. Report Highlights Along with a comprehensive overview of significant findings, High-Throughput Screening (HTS) contains detailed charts and graphs depicting the answers to all 29 survey questions and over 25 cross-tabulations. Below is a glimpse of the key findings derived from just a few of the survey questions: • 76% of respondents perform the majority of their lab's microplate reading applications within their own lab. (Question 2)
• "Enzymatic activity assays" (63%) are the most common microtiter application used among the respondents. (Question 4)
• Many of the respondents' labs (78%) are using UV/VIS detection technologies. (Question 6)
• According to respondents, "background signals" (24%) is the most significant performance limitation/operation problem that their lab experiences with microplate reading equipment. (Question 15)
• Molecular Devices (25%) was the company most frequently mentioned when the respondents were asked which company/supplier comes to mind when they think of microplate readers. (Question 18) (electronic copy also includes 1 print copy) | 
